Daiichi Sankyo Co Ltd

ambit

Japan’s Daiichi Sankyo to acquire US biopharma Ambit Biosciences

29/09/2014(0)
Japanese drugmaker Daiichi Sankyo Co Ltd (4568.T) has agreed to acquire U.S. biopharmaceutical company Ambit Biosciences Corp (AMBI.O) in a deal valued up to $410 million as it looks ... Read More
Broker Cyprus TopFX